Dv Biomed Co Stock Price To Earning
6539 Stock | TWD 45.00 0.50 1.12% |
DV Biomed Co fundamentals help investors to digest information that contributes to DV Biomed's financial success or failures. It also enables traders to predict the movement of 6539 Stock. The fundamental analysis module provides a way to measure DV Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DV Biomed stock.
6539 |
DV Biomed Co Company Price To Earning Analysis
DV Biomed's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current DV Biomed Price To Earning | 13.49 X |
Most of DV Biomed's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DV Biomed Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Based on the latest financial disclosure, DV Biomed Co has a Price To Earning of 13.49 times. This is 47.79% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to earning for all Taiwan stocks is 53.03% higher than that of the company.
6539 Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DV Biomed's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DV Biomed could also be used in its relative valuation, which is a method of valuing DV Biomed by comparing valuation metrics of similar companies.DV Biomed is currently under evaluation in price to earning category among related companies.
6539 Fundamentals
Return On Equity | 23.52 | |||
Return On Asset | 8.85 | |||
Profit Margin | 16.64 % | |||
Operating Margin | 14.88 % | |||
Current Valuation | 3.68 B | |||
Shares Outstanding | 59.26 M | |||
Price To Earning | 13.49 X | |||
Price To Book | 3.33 X | |||
Price To Sales | 2.22 X | |||
Revenue | 1.81 B | |||
Gross Profit | 925.51 M | |||
EBITDA | 448.99 M | |||
Net Income | 301.4 M | |||
Cash And Equivalents | 538.29 M | |||
Cash Per Share | 9.14 X | |||
Total Debt | 249.93 M | |||
Debt To Equity | 0.21 % | |||
Current Ratio | 2.32 X | |||
Book Value Per Share | 20.43 X | |||
Cash Flow From Operations | 463.36 M | |||
Earnings Per Share | 5.04 X | |||
Number Of Employees | 316 | |||
Beta | 0.48 | |||
Market Capitalization | 4.03 B | |||
Z Score | 9.6 | |||
Last Dividend Paid | 1.64 |
About DV Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DV Biomed Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DV Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DV Biomed Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DV Biomed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DV Biomed's short interest history, or implied volatility extrapolated from DV Biomed options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DV Biomed Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for 6539 Stock analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |